Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Unfinished Business: Demonstrating Value In Pharmacogenomic Testing

This article was originally published in The Gray Sheet

Executive Summary

Pharmacogenomic testing and personalized medicine are clearly the wave of the future, but establishing their value to society will be key for their successful adoption, economist Kathryn Phillips, PhD, University of California-San Francisco, maintained at an April 4 symposium sponsored by Johns Hopkins University's Genetics and Public Policy Center

You may also be interested in...



C-Path Institute Exec Targets “Points Of Pain” In Device Development

The Critical Path Institute's new Director of Medical Devices and Imaging, Ellen Feigal, MD, is working with device firms to identify key roadblocks to product development and clear the way to regulatory approval for those products

C-Path Institute Exec Targets “Points Of Pain” In Device Development

The Critical Path Institute's new Director of Medical Devices and Imaging, Ellen Feigal, MD, is working with device firms to identify key roadblocks to product development and clear the way to regulatory approval for those products

Third Wave, Now An IVD Company, Is Banking On Personalized Medicine

Third Wave Technologies is banking on its emerging portfolio of in vitro diagnostic products designed to tailor drug therapy to recover from substantial revenue losses in its research products business

Related Content

UsernamePublicRestriction

Register

MT023459

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel